A stability-indicating RP-HPLC method was developed and validated lbr the determination of Rufinamide in tablet dosage forms using C 18 column (250 mm x 4.6 mm, 5 μm) wilh mobile phase consisting of water acetonitr...A stability-indicating RP-HPLC method was developed and validated lbr the determination of Rufinamide in tablet dosage forms using C 18 column (250 mm x 4.6 mm, 5 μm) wilh mobile phase consisting of water acetonitrile (40:60, v/v) with a [low rate of 0.8 mL/min (UV detection 215 nm). Linearity was observed over the concentration range 1.0 200 μg/mL (R2=0.9997) with regression equation y-113190 x+63053. Rufinamide was subjected to stress conditions including acidic, alkaline, oxidation, photolysis and thermal degradation. Rufinaraide is more sensitive towards acidic degradation. The method was validated as per ICH guidelines.展开更多
文摘A stability-indicating RP-HPLC method was developed and validated lbr the determination of Rufinamide in tablet dosage forms using C 18 column (250 mm x 4.6 mm, 5 μm) wilh mobile phase consisting of water acetonitrile (40:60, v/v) with a [low rate of 0.8 mL/min (UV detection 215 nm). Linearity was observed over the concentration range 1.0 200 μg/mL (R2=0.9997) with regression equation y-113190 x+63053. Rufinamide was subjected to stress conditions including acidic, alkaline, oxidation, photolysis and thermal degradation. Rufinaraide is more sensitive towards acidic degradation. The method was validated as per ICH guidelines.